ENSA_HUMAN - dbPTM
ENSA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ENSA_HUMAN
UniProt AC O43768
Protein Name Alpha-endosulfine
Gene Name ENSA
Organism Homo sapiens (Human).
Sequence Length 121
Subcellular Localization Cytoplasm.
Protein Description Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at Ser-67 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase (By similarity). Also acts as a stimulator of insulin secretion by interacting with sulfonylurea receptor (ABCC8), thereby preventing sulfonylurea from binding to its receptor and reducing K(ATP) channel currents..
Protein Sequence MSQKQEEENPAEETGEEKQDTQEKEGILPERAEEAKLKAKYPSLGQKPGGSDFLMKRLQKGQKYFDSGDYNMAKAKMKNKQLPSAGPDKNLVTGDHIPTPQDLPQRKSSLVTSKLAGGQVE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSQKQEEEN
------CCHHHHCCC
46.1921406692
2Phosphorylation------MSQKQEEEN
------CCHHHHCCC
46.1929255136
2 (in isoform 3)Phosphorylation-46.1927251275
4Ubiquitination----MSQKQEEENPA
----CCHHHHCCCHH
52.9833845483
14PhosphorylationEENPAEETGEEKQDT
CCCHHHHCCCHHHHH
41.2021815630
21PhosphorylationTGEEKQDTQEKEGIL
CCCHHHHHHHHCCCC
35.8123186163
24UbiquitinationEKQDTQEKEGILPER
HHHHHHHHCCCCHHH
51.9624816145
34UbiquitinationILPERAEEAKLKAKY
CCHHHHHHHHHHHCC
50.5524816145
36UbiquitinationPERAEEAKLKAKYPS
HHHHHHHHHHHCCCC
54.5232142685
38UbiquitinationRAEEAKLKAKYPSLG
HHHHHHHHHCCCCCC
41.9724816145
40AcetylationEEAKLKAKYPSLGQK
HHHHHHHCCCCCCCC
56.9925953088
40UbiquitinationEEAKLKAKYPSLGQK
HHHHHHHCCCCCCCC
56.9932142685
41PhosphorylationEAKLKAKYPSLGQKP
HHHHHHCCCCCCCCC
11.6922115753
43PhosphorylationKLKAKYPSLGQKPGG
HHHHCCCCCCCCCCC
41.8823401153
43UbiquitinationKLKAKYPSLGQKPGG
HHHHCCCCCCCCCCC
41.8832015554
43 (in isoform 3)Phosphorylation-41.8827251275
47AcetylationKYPSLGQKPGGSDFL
CCCCCCCCCCCCHHH
43.7825953088
47UbiquitinationKYPSLGQKPGGSDFL
CCCCCCCCCCCCHHH
43.7832015554
51PhosphorylationLGQKPGGSDFLMKRL
CCCCCCCCHHHHHHH
30.9827794612
52UbiquitinationGQKPGGSDFLMKRLQ
CCCCCCCHHHHHHHH
43.9332015554
55SulfoxidationPGGSDFLMKRLQKGQ
CCCCHHHHHHHHHCC
2.1021406390
56MethylationGGSDFLMKRLQKGQK
CCCHHHHHHHHHCCC
52.70-
56UbiquitinationGGSDFLMKRLQKGQK
CCCHHHHHHHHHCCC
52.7023000965
59AcetylationDFLMKRLQKGQKYFD
HHHHHHHHHCCCHHC
52.4419608861
59UbiquitinationDFLMKRLQKGQKYFD
HHHHHHHHHCCCHHC
52.4421890473
59 (in isoform 5)Ubiquitination-52.4421890473
59 (in isoform 6)Ubiquitination-52.4421890473
59 (in isoform 7)Phosphorylation-52.44-
60UbiquitinationFLMKRLQKGQKYFDS
HHHHHHHHCCCHHCC
68.8223000965
63AcetylationKRLQKGQKYFDSGDY
HHHHHCCCHHCCCCH
57.4623954790
63PhosphorylationKRLQKGQKYFDSGDY
HHHHHCCCHHCCCCH
57.4632645325
63UbiquitinationKRLQKGQKYFDSGDY
HHHHHCCCHHCCCCH
57.4623000965
63 (in isoform 1)Ubiquitination-57.4621890473
63 (in isoform 2)Ubiquitination-57.4621890473
63 (in isoform 3)Phosphorylation-57.46-
63 (in isoform 9)Phosphorylation-57.46-
64PhosphorylationRLQKGQKYFDSGDYN
HHHHCCCHHCCCCHH
12.5322167270
67PhosphorylationKGQKYFDSGDYNMAK
HCCCHHCCCCHHHHH
24.5419664994
70PhosphorylationKYFDSGDYNMAKAKM
CHHCCCCHHHHHHHH
15.4625463755
70UbiquitinationKYFDSGDYNMAKAKM
CHHCCCCHHHHHHHH
15.4621890473
72SulfoxidationFDSGDYNMAKAKMKN
HCCCCHHHHHHHHHC
3.0930846556
74AcetylationSGDYNMAKAKMKNKQ
CCCHHHHHHHHHCCC
37.4625953088
74UbiquitinationSGDYNMAKAKMKNKQ
CCCHHHHHHHHHCCC
37.4632015554
76UbiquitinationDYNMAKAKMKNKQLP
CHHHHHHHHHCCCCC
50.1029967540
76 (in isoform 7)Phosphorylation-50.1025159151
79PhosphorylationMAKAKMKNKQLPSAG
HHHHHHHCCCCCCCC
33.5332142685
79 (in isoform 7)Phosphorylation-33.5322496350
80UbiquitinationAKAKMKNKQLPSAGP
HHHHHHCCCCCCCCC
47.9329967540
80 (in isoform 3)Phosphorylation-47.9325159151
80 (in isoform 9)Phosphorylation-47.9325159151
82 (in isoform 7)Phosphorylation-3.7525159151
83PhosphorylationKMKNKQLPSAGPDKN
HHHCCCCCCCCCCCC
21.4632142685
83 (in isoform 3)Phosphorylation-21.4622496350
83 (in isoform 9)Phosphorylation-21.4622496350
84O-linked_GlycosylationMKNKQLPSAGPDKNL
HHCCCCCCCCCCCCC
55.22OGP
84PhosphorylationMKNKQLPSAGPDKNL
HHCCCCCCCCCCCCC
55.2220068231
85UbiquitinationKNKQLPSAGPDKNLV
HCCCCCCCCCCCCCC
31.4329967540
86UbiquitinationNKQLPSAGPDKNLVT
CCCCCCCCCCCCCCC
34.9621890473
86 (in isoform 3)Phosphorylation-34.9625159151
86 (in isoform 7)Ubiquitination-34.9621890473
86 (in isoform 9)Phosphorylation-34.9625159151
89AcetylationLPSAGPDKNLVTGDH
CCCCCCCCCCCCCCC
56.1425953088
89UbiquitinationLPSAGPDKNLVTGDH
CCCCCCCCCCCCCCC
56.1429967540
90UbiquitinationPSAGPDKNLVTGDHI
CCCCCCCCCCCCCCC
47.3121890473
90 (in isoform 3)Ubiquitination-47.3121890473
90 (in isoform 4)Phosphorylation-47.3122496350
92UbiquitinationAGPDKNLVTGDHIPT
CCCCCCCCCCCCCCC
8.6429967540
93O-linked_GlycosylationGPDKNLVTGDHIPTP
CCCCCCCCCCCCCCC
39.8131373491
93PhosphorylationGPDKNLVTGDHIPTP
CCCCCCCCCCCCCCC
39.8126074081
93 (in isoform 4)Phosphorylation-39.8127155012
96UbiquitinationKNLVTGDHIPTPQDL
CCCCCCCCCCCCCCC
29.3129967540
97 (in isoform 4)Ubiquitination-4.9021890473
99O-linked_GlycosylationVTGDHIPTPQDLPQR
CCCCCCCCCCCCCCH
32.7430838711
99PhosphorylationVTGDHIPTPQDLPQR
CCCCCCCCCCCCCCH
32.7425159151
100 (in isoform 3)Phosphorylation-21.9727251275
101UbiquitinationGDHIPTPQDLPQRKS
CCCCCCCCCCCCHHH
68.3129967540
103UbiquitinationHIPTPQDLPQRKSSL
CCCCCCCCCCHHHHH
3.0729967540
104 (in isoform 6)Phosphorylation-39.9725849741
105PhosphorylationPTPQDLPQRKSSLVT
CCCCCCCCHHHHHHH
73.1332142685
105UbiquitinationPTPQDLPQRKSSLVT
CCCCCCCCHHHHHHH
73.1329967540
105 (in isoform 6)Phosphorylation-73.1325849741
107UbiquitinationPQDLPQRKSSLVTSK
CCCCCCHHHHHHHHH
38.8729967540
108PhosphorylationQDLPQRKSSLVTSKL
CCCCCHHHHHHHHHH
30.9727273156
108 (in isoform 2)Phosphorylation-30.9725849741
108 (in isoform 6)Phosphorylation-30.9717924679
109PhosphorylationDLPQRKSSLVTSKLA
CCCCHHHHHHHHHHC
29.8723927012
109 (in isoform 2)Phosphorylation-29.8725849741
109 (in isoform 6)Phosphorylation-29.8719651622
110UbiquitinationLPQRKSSLVTSKLAG
CCCHHHHHHHHHHCC
6.6824816145
112PhosphorylationQRKSSLVTSKLAGGQ
CHHHHHHHHHHCCCC
25.9930266825
112 (in isoform 2)Phosphorylation-25.9917924679
113PhosphorylationRKSSLVTSKLAGGQV
HHHHHHHHHHCCCCC
20.4223927012
113 (in isoform 2)Phosphorylation-20.4219651622
114AcetylationKSSLVTSKLAGGQVE
HHHHHHHHHCCCCCC
32.7525953088
114UbiquitinationKSSLVTSKLAGGQVE
HHHHHHHHHCCCCCC
32.7524816145
115 (in isoform 3)Phosphorylation-5.5427251275
119UbiquitinationTSKLAGGQVE-----
HHHHCCCCCC-----
34.9429967540
121PhosphorylationKLAGGQVE-------
HHCCCCCC-------
47.2032142685
123UbiquitinationAGGQVE---------
CCCCCC---------
29967540
124 (in isoform 3)Phosphorylation-27251275
124 (in isoform 9)Phosphorylation-25849741
125PhosphorylationGQVE-----------
CCCC-----------
32142685
125 (in isoform 3)Phosphorylation-27251275
125 (in isoform 9)Phosphorylation-25849741
126UbiquitinationQVE------------
CCC------------
24816145
128 (in isoform 9)Phosphorylation-17924679
129 (in isoform 9)Phosphorylation-19651622
130Ubiquitination----------------
----------------
24816145
131 (in isoform 4)Phosphorylation-25849741
132 (in isoform 4)Phosphorylation-25849741
135 (in isoform 4)Phosphorylation-17924679
136 (in isoform 4)Phosphorylation-19651622

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
67SPhosphorylationKinaseMASTLQ96GX5
PSP
109SPhosphorylationKinasePKACAP17612
PSP
109SPhosphorylationKinasePKG1Q13976
PSP
109SPhosphorylationKinasePKA-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
67SPhosphorylation

9653196

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ENSA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MCM3_HUMANMCM3physical
17353931
OFD1_HUMANOFD1physical
28514442
RPP25_HUMANRPP25physical
28514442
DPP9_HUMANDPP9physical
28514442
PEX6_HUMANPEX6physical
28514442
UBB_HUMANUBBphysical
28514442
QSOX1_HUMANQSOX1physical
28514442
UBP4_HUMANUSP4physical
28514442
CBX5_HUMANCBX5physical
28514442
IREB2_HUMANIREB2physical
28514442
DD19B_HUMANDDX19Bphysical
28514442
POP7_HUMANPOP7physical
28514442
AT12A_HUMANATP12Aphysical
28514442
RIC8B_HUMANRIC8Bphysical
28514442
PPME1_HUMANPPME1physical
28514442
MTMR4_HUMANMTMR4physical
28514442
PGTA_HUMANRABGGTAphysical
28514442
SCPDL_HUMANSCCPDHphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ENSA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Membrane-induced folding of the cAMP-regulated phosphoproteinendosulfine-alpha.";
Boettcher J.M., Hartman K.L., Ladror D.T., Qi Z., Woods W.S.,George J.M., Rienstra C.M.;
Biochemistry 47:12357-12364(2008).
Cited for: INTERACTION WITH SNCA, PHOSPHORYLATION AT SER-109, AND MUTAGENESIS OFSER-109.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43 AND TYR-70, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-109; THR-112AND SER-113, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-70, AND MASSSPECTROMETRY.

TOP